Page - (000408) - in Biomedical Chemistry: Current Trends and Developments

173(5), 1099-1109. Pinheiro AV1, H. D., Shih WM, Yan H. (2011). Challenges and opportunities for structural DNA nanotechnology. Nature Nanotechnology, 6, 763–772. Poon, Z., Lee, J. B., Morton, S. W., et al. (2011). Controlling in vivo stability and biodistribution in electrostatically assembled nanoparticles for systemic delivery. Nano Letters, 11(5), 2096- 2103. Power, S., Slattery, M. M., Lee, M. J. (2011). Nanotechnology and its relationship to interventional radiology. Part i: Imaging. CardioVascular and Interventional Radiology, 34(2), 221-226. Prabhakar, U., Maeda, H., Jain, R. K., et al. (2013). Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Research, 73(8), 2412-2417. Prang, N., Preithner, S., Brischwein, K., et al. (2005). Cellular and complement-dependent cytotoxicity of ep-cam-specific monoclonal antibody mt201 against breast cancer cell lines. British Journal of Cancer, 92(2), 342-349. Primard, C., Rochereau, N., Luciani, E., et al. (2010). Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells. Biomaterials, 31(23), 6060-6068. Ramakrishna, V., Treml, J. F., Vitale, L., et al. (2004). Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma t cell responses via multiple hla molecules. Journal of Immunology, 172(5), 2845-2852. Rappuoli, R., Aderem, A. (2011). A 2020 vision for vaccines against hiv, tuberculosis and malaria. Nature, 473(7348), 463-469. Reddy, A. K., Rathinaraj, B. S., Prathyusha, P., et al. (2011). Emerging trends of nanotechnology in cancer therapy. International Journal of Pharmaceutical & Biological Archives, 2(1). Reddy, S. T., van der Vlies, A. J., Simeoni, E., et al. (2007). Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nature Biotechnology, 25(10), 1159-1164. Reichert, S., Welker, P., Calderon, M., et al. (2011). Size-dependant cellular uptake of dendritic polyglycerol. Small, 7(6), 820-829. Reischl, D., Zimmer, A. (2009). Drug delivery of sirna therapeutics: Potentials and limits of nanosystems. Nanomedicine, 5(1), 8-20. Remant, B. K., Chandrashekaran, V., Cheng, B., et al. (2014). Redox potential ultrasensitive nanoparticle for the targeted delivery of camptothecin to her2-positive cancer cells. Molecular Pharmaceutics, 11(6), 1897-1905. Reyes-Aldasoro, C. C., Wilson, I., Prise, V. E., et al. (2008). Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of p22 rat sarcomas in vivo. Microcirculation, 15(1), 65-79. Rosen, J. E., Chan, L., Shieh, D.-B., et al. (2012). Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine: Nanotechnology, Biology and Medicine, 8(3), 275- 290. Rosen JE, Y. S., Meerasa A., Verma M., Gu F.X., et al. (2011). Nanotechnology and diagnostic imaging: New advances in contrast agent technology. Journal of Nanomedicine & Nanotechnology, 2(5), 115. DOI: 10.4172/2157-7439.1000115. Rosenberg, S. A. (1988). The development of new immunotherapies for the treatment of cancer